Lung Ultrasound Patterns and Clinical-Laboratory Correlates During COVID-19 Pneumonia: A Retrospective Study from North East Italy
Overview
Authors
Affiliations
Background And Aim: Lung ultrasound (LUS) is a convenient imaging modality in the setting of coronavirus disease-19 (COVID-19) because it is easily available, can be performed bedside and repeated over time. We herein examined LUS patterns in relation to disease severity and disease stage among patients with COVID-19 pneumonia.
Methods: We performed a retrospective case series analysis of patients with confirmed SARS-CoV-2 infection who were admitted to the hospital because of pneumonia. We recorded history, clinical parameters and medications. LUS was performed and scored in a standardized fashion by experienced operators, with evaluation of up to 12 lung fields, reporting especially on B-lines and consolidations.
Results: We included 96 patients, 58.3% men, with a mean age of 65.9 years. Patients with a high-risk quick COVID-19 severity index (qCSI) were older and had worse outcomes, especially for the need for high-flow oxygen. B-lines and consolidations were located mainly in the lower posterior lung fields. LUS patterns for B-lines and consolidations were significantly worse in all lung fields among patients with high versus low qCSI. B-lines and consolidations were worse in the intermediate disease stage, from day 7 to 13 after onset of symptoms. While consolidations correlated more with inflammatory biomarkers, B-lines correlated more with end-organ damage, including extrapulmonary involvement.
Conclusions: LUS patterns provide a comprehensive evaluation of patients with COVID-19 pneumonia that correlated with severity and dynamically reflect disease stage. LUS patterns may reflect different pathophysiological processes related to inflammation or tissue damage; consolidations may represent a more specific sign of localized disease, whereas B-lines seem to be also dependent upon generalized illness due to SARS-CoV-2 infection.
Walsh P, Hankins A, Bang H Sci Rep. 2024; 14(1):5899.
PMID: 38467670 PMC: 10928070. DOI: 10.1038/s41598-024-55590-9.
Huang C, Zhang S, Ha X, Cui Y, Zhang H Front Med (Lausanne). 2024; 11:1357944.
PMID: 38390571 PMC: 10881781. DOI: 10.3389/fmed.2024.1357944.
Lung Ultrasound as a Triage Method in Primary Care for Patients with Suspected SARS-CoV-2 Pneumonia.
Guzman-Garcia M, Mohedano-Moriano A, Gonzalez-Gonzalez J, Morales-Cano J, Campo-Linares R, Lozano-Suarez C J Clin Med. 2022; 11(21).
PMID: 36362647 PMC: 9657854. DOI: 10.3390/jcm11216420.
Lung Ultrasound Findings and Endothelial Perturbation in a COVID-19 Low-Intensity Care Unit.
Gualtierotti R, Tafuri F, Rossio R, Rota M, Bucciarelli P, Ferrari B J Clin Med. 2022; 11(18).
PMID: 36143072 PMC: 9504266. DOI: 10.3390/jcm11185425.
New International Guidelines and Consensus on the Use of Lung Ultrasound.
Demi L, Wolfram F, Klersy C, De Silvestri A, Ferretti V, Muller M J Ultrasound Med. 2022; 42(2):309-344.
PMID: 35993596 PMC: 10086956. DOI: 10.1002/jum.16088.